Ipilimumab/nivolumab/vancomycinVarious toxicities and off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1947卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35381-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：241 / 241

相关论文

共 50 条

[41] PrednisoloneVarious toxicities and off-label use: case report
Reactions Weekly, 2023, 1945 (1) : 452 - 452
[42] Metronidazole/vancomycinVarious toxicities: case report
Reactions Weekly, 2017, 1654 (1) : 226 - 226
[43] Multiple drugsVarious toxicities and off label use: case report
Reactions Weekly, 2022, 1924 (1) : 340 - 340
[44] DaratumumabVarious toxicities and off-label use: case report
Reactions Weekly, 2023, 1965 (1) : 174 - 174
[45] OlanzapineVarious toxicities following off label use: case report
Reactions Weekly, 2021, 1883 (1) : 302 - 302
[46] PazopanibVarious toxicities following off label use: case report
Reactions Weekly, 2017, 1663 (1) : 243 - 243
[47] ImmunosuppressantsVarious toxicities and off-label use: case report
Reactions Weekly, 2022, 1898 (1) : 225 - 225
[48] Cabozantinib/sorafenibVarious toxicities and off label use: case report
Reactions Weekly, 2022, 1894 (1) : 85 - 85
[49] Citalopram/gliclazideVarious toxicities and off label use : case report
Reactions Weekly, 2023, 1969 (1) : 123 - 123
[50] MidostaurinVarious toxicities following an off label use: case report
Reactions Weekly, 2019, 1782 (1) : 221 - 221

← 1 2 3 4 5 →